Phase III

1 stories · following the connections

Business

VBI Vaccines Announces Initiation of Phase 3 Clinical Program for Sci-B-Vac® Hepatitis B Vaccine

By Nasdaq OMXDec 19, 2017, 1:00 PM UTC